-
Something wrong with this record ?
Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression
L. Krskova, A. Augustinakova, E. Drahokoupilova, D. Sumerauer, P. Mudry, R. Kodet,
Language English Country Slovakia
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Rhabdomyosarcoma, Alveolar genetics MeSH
- Adult MeSH
- Rhabdomyosarcoma, Embryonal genetics MeSH
- Oncogene Proteins, Fusion genetics MeSH
- Insulin-Like Growth Factor II genetics MeSH
- Muscle, Skeletal metabolism pathology MeSH
- Bone Marrow metabolism pathology MeSH
- Humans MeSH
- RNA, Messenger genetics MeSH
- Survival Rate MeSH
- MyoD Protein genetics MeSH
- Myogenin genetics MeSH
- Biomarkers, Tumor genetics MeSH
- Reverse Transcriptase Polymerase Chain Reaction MeSH
- Prognosis MeSH
- PAX7 Transcription Factor genetics MeSH
- Loss of Heterozygosity MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. There are two major histopathological types of RMS – embryonal (eRMS) and alveolar (aRMS). A molecular study of Igf2, MyoD1 and Myogenin was performed to determine the expression profiles and to assess the possible utility of these genes as potential treatment targets. Patients with RMS showed up to 100-fold increase of Igf2 transcription in comparison with normal skeletal muscle. Our data suggest that overexpression of Igf2 occurs in RMS of both histological subtypes. No correlation between the results of Igf2 mRNA expression and LOH at the 11p15 region (p= 0.12) was observed, but there was a trend of a higher expression of Igf2 mRNA in RMS samples with LOH. We observed a high level of MyoD1 mRNA in both aRMS and eRMS, and we detected a similar level of MyoD1 mRNA in RMS and normal skeletal muscles. There was a correlation between the results of MyoD1 mRNA expression and LOH at the 11p15 region.We did not observe any statistical difference in the level of Myogenin mRNA in the subgroups of RMS. Analogous to MyoD1, we observed a similar level of Myogenin mRNA in RMS and normal skeletal muscles.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027471
- 003
- CZ-PrNML
- 005
- 20121210094323.0
- 007
- ta
- 008
- 120817s2011 xo f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.4149/neo_2011_05_415 $2 doi
- 035 __
- $a (PubMed)21744995
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Krskova, L $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Faculty Hospital in Motol, Prague, Czech Republic. lkrskova@email.cz
- 245 10
- $a Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression / $c L. Krskova, A. Augustinakova, E. Drahokoupilova, D. Sumerauer, P. Mudry, R. Kodet,
- 520 9_
- $a Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. There are two major histopathological types of RMS – embryonal (eRMS) and alveolar (aRMS). A molecular study of Igf2, MyoD1 and Myogenin was performed to determine the expression profiles and to assess the possible utility of these genes as potential treatment targets. Patients with RMS showed up to 100-fold increase of Igf2 transcription in comparison with normal skeletal muscle. Our data suggest that overexpression of Igf2 occurs in RMS of both histological subtypes. No correlation between the results of Igf2 mRNA expression and LOH at the 11p15 region (p= 0.12) was observed, but there was a trend of a higher expression of Igf2 mRNA in RMS samples with LOH. We observed a high level of MyoD1 mRNA in both aRMS and eRMS, and we detected a similar level of MyoD1 mRNA in RMS and normal skeletal muscles. There was a correlation between the results of MyoD1 mRNA expression and LOH at the 11p15 region.We did not observe any statistical difference in the level of Myogenin mRNA in the subgroups of RMS. Analogous to MyoD1, we observed a similar level of Myogenin mRNA in RMS and normal skeletal muscles.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kostní dřeň $x metabolismus $x patologie $7 D001853
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a insulinu podobný růstový faktor II $x genetika $7 D007335
- 650 _2
- $a ztráta heterozygozity $7 D019656
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a kosterní svaly $x metabolismus $x patologie $7 D018482
- 650 _2
- $a MyoD Protein $x genetika $7 D017570
- 650 _2
- $a myogenin $x genetika $7 D018008
- 650 _2
- $a fúzní onkogenní proteiny $x genetika $7 D015514
- 650 _2
- $a transkripční faktor PAX7 $x genetika $7 D051763
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a alveolární rhabdomyosarkom $x genetika $7 D018232
- 650 _2
- $a embryonální rhabdomyosarkom $x genetika $7 D018233
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Augustinakova, A $7 gn_A_00010061
- 700 1_
- $a Drahokoupilova, E
- 700 1_
- $a Sumerauer, D
- 700 1_
- $a Mudry, P
- 700 1_
- $a Kodet, R
- 773 0_
- $w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 58, č. 5 (2011), s. 415-23
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21744995 $y Pubmed
- 910 __
- $a ABA008 $b A 1194 $c 659 $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210094359 $b ABA008
- 999 __
- $a ok $b bmc $g 949513 $s 784817
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 58 $c 5 $d 415-23 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- LZP __
- $a Pubmed-20120817/11/03